Cargando…

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

BACKGROUND: We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such liraglutide-induced improvement is maintained after discha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujishima, Yuya, Maeda, Norikazu, Inoue, Kana, Kashine, Susumu, Nishizawa, Hitoshi, Hirata, Ayumu, Kozawa, Junji, Yasuda, Tetsuyuki, Okita, Kohei, Imagawa, Akihisa, Funahashi, Tohru, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459720/ https://www.ncbi.nlm.nih.gov/pubmed/22973968 http://dx.doi.org/10.1186/1475-2840-11-107

Ejemplares similares

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
por: Inoue, Kana, et al.
Publicado: (2011)

Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
por: Inoue, Kana, et al.
Publicado: (2014)

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2015)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity
por: Nagao, Hirofumi, et al.
Publicado: (2013)

Characteristics of sleep–wake cycle and sleep duration in Japanese type 2 diabetes patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2017)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy
por: Nagai, Yasuki, et al.
Publicado: (2018)

A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells
por: Yamaoka, Masaya, et al.
Publicado: (2012)

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients
por: Kozawa, Junji, et al.
Publicado: (2011)

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient
por: D Hayashi, Reiko, et al.
Publicado: (2017)

An Impaired Awareness of Hypoglycemia Improved After Vitamin B(12) Treatment in a Type 1 Diabetic Patient
por: Fujita, Shingo, et al.
Publicado: (2017)

A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study
por: Hibuse, Toshiyuki, et al.
Publicado: (2014)

Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity
por: Inoue, Kana, et al.
Publicado: (2013)

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

A Japanese patient with a 2p25.3 terminal deletion presented with early‐onset obesity, intellectual disability and diabetes mellitus: A case report
por: Sakaue, Taka‐aki, et al.
Publicado: (2021)

Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
por: Uno, Sae, et al.
Publicado: (2017)

A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
por: Tabuchi, Yukiko, et al.
Publicado: (2012)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
por: Hirata, Ayumu, et al.
Publicado: (2012)

Weight reduction is associated with improvement of glycemic control in Japanese men, whose hemoglobin A1C is 5.6–6.4%, with visceral fat accumulation, but not without visceral fat accumulation
por: Okauchi, Yukiyoshi, et al.
Publicado: (2013)

Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice
por: Mori, Takuya, et al.
Publicado: (2014)

Adiponectin Protein Exists in Aortic Endothelial Cells
por: Komura, Noriyuki, et al.
Publicado: (2013)

Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan
por: Fujita, Shingo, et al.
Publicado: (2017)

Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Natsukawa, Tomoaki, et al.
Publicado: (2017)

Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study
por: Okauchi, Yukiyoshi, et al.
Publicado: (2011)

Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade
por: Kawada-Horitani, Emi, et al.
Publicado: (2022)

Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue
por: Baden, Megu Yamaguchi, et al.
Publicado: (2015)

Insulin‐secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non‐obese Japanese patients
por: Iwahashi, Hiromi, et al.
Publicado: (2012)

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients
por: Kawamori, Dan, et al.
Publicado: (2018)

Case of a novel PAX6 mutation with aniridia and insulin‐dependent diabetes mellitus
por: Motoda, Saori, et al.
Publicado: (2018)

Human pancreatic α‐ to β‐cell area ratio increases after type 2 diabetes onset
por: Fujita, Yukari, et al.
Publicado: (2018)

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
por: Kawamori, Dan, et al.
Publicado: (2019)

Ectopic Fat Accumulation in Pancreas and Heart
por: Kozawa, Junji, et al.
Publicado: (2021)

Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated
por: Osawa, Saeko, et al.
Publicado: (2015)

A Novel Role for Adipose Ephrin-B1 in Inflammatory Response
por: Mori, Takuya, et al.
Publicado: (2013)

Possible Involvement of Opa-Interacting Protein 5 in Adipose Proliferation and Obesity
por: Inoue, Kana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_viv19tnea26s68om8gfkdfd6cu